VanEck Associates’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.1M | Sell |
443,697
-63,704
| -13% | -$9.27M | 0.04% | 235 |
|
|
2026
Q1 | $73.3M | Buy |
507,401
+12,072
| +2% | +$1.83M | 0.06% | 219 |
|
|
2025
Q4 | $71M | Buy |
495,329
+35,716
| +8% | +$5.27M | 0.06% | 192 |
|
|
2025
Q3 | $70.6M | Buy |
459,613
+8,923
| +2% | +$1.39M | 0.07% | 180 |
|
|
2025
Q2 | $71.8M | Sell |
450,690
-24,626
| -5% | -$4.02M | 0.08% | 170 |
|
|
2025
Q1 | $81M | Buy |
475,316
+8,819
| +2% | +$1.48M | 0.1% | 144 |
|
|
2024
Q4 | $78.2M | Buy |
466,497
+44,163
| +10% | +$7.52M | 0.1% | 142 |
|
|
2024
Q3 | $71.6M | Buy |
422,334
+37,609
| +10% | +$6.38M | 0.09% | 143 |
|
|
2024
Q2 | $63.4M | Buy |
384,725
+23,853
| +7% | +$3.9M | 0.09% | 151 |
|
|
2024
Q1 | $58.6M | Buy |
360,872
+23,611
| +7% | +$3.7M | 0.09% | 148 |
|
|
2023
Q4 | $49.4M | Buy |
337,261
+318,748
| +1,722% | +$47.2M | 0.09% | 151 |
|
|
2023
Q3 | $2.7M | Buy |
18,513
+2,397
| +15% | +$366K | 0.01% | 671 |
|
|
2023
Q2 | $2.44M | Sell |
16,116
-86
| -0.5% | -$13K | 0.01% | 676 |
|
|
2023
Q1 | $2.41M | Buy |
16,202
+1,852
| +13% | +$265K | 0.01% | 664 |
|
|
2022
Q4 | $2.17M | Buy |
14,350
+480
| +3% | +$67.3K | 0.01% | 665 |
|
|
2022
Q3 | $1.75M | Sell |
13,870
-1,079
| -7% | -$153K | 0.01% | 678 |
|
|
2022
Q2 | $2.15M | Buy |
14,949
+630
| +4% | +$94.7K | 0.01% | 647 |
|
|
2022
Q1 | $2.19M | Sell |
14,319
-2,482
| -15% | -$388K | ﹤0.01% | 683 |
|
|
2021
Q4 | $2.75M | Sell |
16,801
-943
| -5% | -$140K | 0.01% | 635 |
|
|
2021
Q3 | $2.48M | Sell |
17,744
-14,904
| -46% | -$2.11M | 0.01% | 616 |
|
|
2021
Q2 | $4.41M | Sell |
32,648
-192,532
| -86% | -$26.1M | 0.01% | 485 |
|
|
2021
Q1 | $30.5M | Buy |
225,180
+36,721
| +19% | +$4.79M | 0.08% | 180 |
|
|
2020
Q4 | $26.2M | Buy |
188,459
+26,376
| +16% | +$3.69M | 0.08% | 187 |
|
|
2020
Q3 | $22.5M | Buy |
162,083
+153
| +0.1% | +$20.3K | 0.07% | 169 |
|
|
2020
Q2 | $19.4M | Buy |
161,930
+16,043
| +11% | +$1.87M | 0.07% | 180 |
|
|
2020
Q1 | $16M | Buy |
145,887
+6,725
| +5% | +$807K | 0.08% | 163 |
|
|
2019
Q4 | $17.4M | Buy |
139,162
+99,738
| +253% | +$12.2M | 0.07% | 193 |
|
|
2019
Q3 | $4.9M | Sell |
39,424
-3,959
| -9% | -$468K | 0.02% | 345 |
|
|
2019
Q2 | $4.76M | Sell |
43,383
-1,219
| -3% | -$130K | 0.02% | 349 |
|
|
2019
Q1 | $4.64M | Sell |
44,602
-281,824
| -86% | -$27.4M | 0.02% | 337 |
|
|
2018
Q4 | $30M | Sell |
326,426
-210,215
| -39% | -$18.8M | 0.15% | 125 |
|
|
2018
Q3 | $44.7M | Buy |
536,641
+15,362
| +3% | +$1.26M | 0.22% | 105 |
|
|
2018
Q2 | $40.7M | Buy |
521,279
+289,394
| +125% | +$21.8M | 0.19% | 112 |
|
|
2018
Q1 | $18.4M | Buy |
+231,885
| New | +$19.3M | 0.09% | 179 |
|
|
2015
Q4 | – | Sell |
-551,936
| Closed | -$39.7M | – | 792 |
|
|
2015
Q3 | $39.7M | Buy |
+551,936
| New | +$41.4M | 0.31% | 76 |
|
|
2014
Q4 | – | Sell |
-517,623
| Closed | -$43.3M | – | 807 |
|
|
2014
Q3 | $43.3M | Buy |
517,623
+54,551
| +12% | +$4.47M | 0.23% | 105 |
|
|
2014
Q2 | $36.4M | Buy |
463,072
+64,906
| +16% | +$5.23M | 0.17% | 121 |
|
|
2014
Q1 | $32.1M | Buy |
+398,166
| New | +$31.4M | 0.16% | 111 |
|
Other funds holding PG
VanEck Associates's PG Position: Q2 2026 in Review
VanEck Associates reduced its Procter & Gamble (PG) stake by 13% in Q2 2026, selling an estimated $9.27M and leaving 443,697 shares worth $65.1M. The position accounts for 0.04% of the portfolio, ranked #235.
VanEck Associates first reported a position in PG in Q1 2014 and has held it in 38 quarters since. The position peaked at $81M in Q1 2025. 3,994 funds tracked by Wall St. Rank hold PG as of Q2 2026.
- VanEck Associates held 443,697 shares of Procter & Gamble worth $65.1M as of Q2 2026.
- VanEck Associates sold 63,704 Procter & Gamble shares in Q2 2026, an estimated $9.27M.
- Procter & Gamble made up 0.04% of VanEck Associates's portfolio in Q2 2026, its #235 holding.
- VanEck Associates first reported a position in Procter & Gamble in Q1 2014 and has held it in 38 quarters since.
- VanEck Associates's Procter & Gamble position peaked at $81M in Q1 2025.
- 3,994 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.